13D/13G Filings - Atlas Venture Fund IX L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-01-31
08:57 am
Unchanged		 2022-12-31 13G Surface Oncology, Inc.
SURF		 Atlas Venture Fund IX L.P. 2,945,453
4.870%		 0
(Unchanged)		 Filing
History
2022-01-25
11:32 am
Unchanged		 2021-12-31 13G Cogent Biosciences, Inc.
COGT		 Atlas Venture Fund IX L.P. 916,196
2.300%		 0
(Unchanged)		 Filing
History
2022-01-25
11:30 am
Unchanged		 2021-12-31 13G Surface Oncology, Inc.
SURF		 Atlas Venture Fund IX L.P. 2,945,453
6.380%		 0
(Unchanged)		 Filing
History
2022-01-25
11:28 am
Unchanged		 2021-12-31 13G Spero Therapeutics, Inc.
SPRO		 Atlas Venture Fund IX L.P. 1,376,968
4.260%		 0
(Unchanged)		 Filing
History
2021-02-02
1:03 pm
Sale		 2020-12-31 13G Surface Oncology, Inc.
SURF		 Atlas Venture Fund IX L.P. 2,945,453
7.240%		 -1,709,000decrease
(-36.72%)		 Filing
History
2021-02-02
1:02 pm
Unchanged		 2020-12-31 13G Spero Therapeutics, Inc.
SPRO		 Atlas Venture Fund IX L.P. 1,376,968
5.060%		 0
(Unchanged)		 Filing
History
2021-02-02
1:02 pm
Purchase		 2020-12-31 13G Cogent Biosciences, Inc.
COGT		 Atlas Venture Fund IX L.P. 916,196
8.080%		 916,196increase
(New Position)		 Filing
History
2020-12-28
07:39 am
Purchase		 2020-12-16 13D Skillz Inc.
SKLZ		 Atlas Venture Fund IX L.P. 1,164,220
8.000%		 1,164,220increase
(New Position)		 Filing
History